ATE115951T1 - Glycocyamidin-derivate. - Google Patents

Glycocyamidin-derivate.

Info

Publication number
ATE115951T1
ATE115951T1 AT90810073T AT90810073T ATE115951T1 AT E115951 T1 ATE115951 T1 AT E115951T1 AT 90810073 T AT90810073 T AT 90810073T AT 90810073 T AT90810073 T AT 90810073T AT E115951 T1 ATE115951 T1 AT E115951T1
Authority
AT
Austria
Prior art keywords
glycocyamidine
derivatives
alkyl group
hydrogen
chem
Prior art date
Application number
AT90810073T
Other languages
English (en)
Inventor
Ko Nakamura
Kazuhara Ienaga
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE115951T1 publication Critical patent/ATE115951T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90810073T 1989-02-01 1990-01-31 Glycocyamidin-derivate. ATE115951T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2466989 1989-02-01

Publications (1)

Publication Number Publication Date
ATE115951T1 true ATE115951T1 (de) 1995-01-15

Family

ID=12144550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90810073T ATE115951T1 (de) 1989-02-01 1990-01-31 Glycocyamidin-derivate.

Country Status (7)

Country Link
US (1) US4957936A (de)
EP (1) EP0381628B1 (de)
JP (1) JP2957217B2 (de)
AT (1) ATE115951T1 (de)
DE (1) DE69015220T2 (de)
DK (1) DK0381628T3 (de)
ES (1) ES2066181T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221689B (de) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
WO2005072082A2 (en) * 2003-11-21 2005-08-11 U.S. Army Medical Research And Materiel Command 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
WO2011136228A1 (ja) 2010-04-27 2011-11-03 シスメックス株式会社 腎臓病診断用マーカー及びその利用
US20190046507A1 (en) * 2016-02-18 2019-02-14 Merck Sharp & Dohme Corp. Compounds for the treatment of malaria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE251937C (de) *
US4657922A (en) * 1985-05-24 1987-04-14 Mcneilab, Inc. Anxiolytic 4,5-dihydro-4-oxo-1H-imidazol-2-yl urea derivatives

Also Published As

Publication number Publication date
ES2066181T3 (es) 1995-03-01
EP0381628A2 (de) 1990-08-08
DK0381628T3 (da) 1995-05-01
JP2957217B2 (ja) 1999-10-04
EP0381628A3 (de) 1991-05-02
DE69015220D1 (de) 1995-02-02
EP0381628B1 (de) 1994-12-21
JPH02288867A (ja) 1990-11-28
DE69015220T2 (de) 1995-05-11
US4957936A (en) 1990-09-18

Similar Documents

Publication Publication Date Title
AU515774B2 (en) Benzopyran derivatives
ATE96426T1 (de) Diphenylharnstoffderivate.
ATE59391T1 (de) Oliglucosidderivate.
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
ES548357A0 (es) Procedimiento para preparar derivados de n-(adamantil-1)-pirrolidon-5-carboxamida-2.
FI913067A0 (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
ES2188481T3 (es) Derivados de polinalbufina.
ES2065994T3 (es) Beta-dicetonas substituidas.
MX170732B (es) Composicion de derivados de succinimida y su uso
DK0381628T3 (da) Glycocyamidinderivater
FI854596A0 (fi) Nytt foerfarande foer uppdelning av racemiska -naftylpropionsyror i optiska isomerer.
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
DK0485204T3 (da) Fremgangsmåde til fremstilling af 3-alkoxymethyl-cephalosporin-derivater
KR890008151A (ko) 키놀린 카르복산의 유도체
DE69805267D1 (de) Cyclopropancyclus enthaltende Purinderivate
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
KR890011830A (ko) 2-옥시이미노 -3- 옥소부티르산의 제조방법
ATE86629T1 (de) 4-piperidincarboxamid-derivate.
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE119909T1 (de) 3-deoxymycaminosyltylonolidderivate.
KR860008184A (ko) 디옥솔로벤조이소옥사졸 유도체의 제법
DK0455899T3 (da) Prostaglandin I-analog
KR840001554A (ko) 벤즈아미드 유도체의 제법
DE69333903D1 (de) Optisch aktive 1-Phenylpyrrolidonderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee